From the Journals
Screening criteria for diabetes in youth won’t capture all at high risk
A1c in particular appears useful regardless of whether screening criteria are met.
Conference Coverage
Intermittent fasting ‘not benign’ for patients with diabetes
The “big issue” for such individuals who undertake intermittent fasting is hypoglycemia, so caloric restriction may be a better choice for some...
Conference Coverage
Cognitive deficits complex in youths with type 2 diabetes
Average fluid cognition scores were significantly lower versus youths with type 1 diabetes, a difference investigators said was due to further...
Sponsored Supplement
Headline can be up to 255 characters
Conference Coverage
T2D plus heart failure packs a deadly punch
Medical records from 150,000 Danish patients with type 2 diabetes showed heart failure comorbidity was the deadliest combination.
Conference Coverage
Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFR
Another dimension of dapagliflozin’s renal protection for type 2 diabetes patients is shown in a post-hoc analysis from its cardiovascular...
Conference Coverage
Robotics lightens load for bariatric surgeons in super obese
Conference Coverage
Weight loss stays consistent in one- and two-step in gastric band conversion
Patients who underwent two-step conversions to LSG after LAGB showed increased BMI between procedures.
Conference Coverage
For COVID-19 plus diabetes, glycemic control tops treatment list
Tight glucose control led to better results in patients with diabetes and COVID-19.
Conference Coverage
Diabetes hospitalizations halved with FreeStyle Libre glucose monitor
Hospitalizations for diabetic ketoacidosis, diabetes-related emergencies, and all-cause hospitalizations were reduced following initiation of...
Conference Coverage
High-frequency spinal cord stimulation eases painful diabetic neuropathy
Conference Coverage
Starting new diabetes drugs less likely for racial minorities, Medicare Advantage beneficiaries
More work is needed to understand why DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors are not being used as often in patients that...
Conference Coverage
EMPA-REG OUTCOME: Empagliflozin cut insulin need in type 2 diabetes
Post-hoc analysis from EMPA-REG OUTCOME showed that type 2 diabetes patients who received empagliflozin had less need for insulin than controls....
From the Journals
Half of type 1 diabetes patients with COVID-19 manage at home
Despite high rates of hyperglycemia and DKA, only about half of patients with type 1 diabetes and COVID-19 required hospitalization, according to...
Conference Coverage
Virtual ADA Scientific Sessions to offer full program
Program features fewer blockbuster trials than in years past but plenty of meaty clinical material.
From the Journals
Glucose control linked to COVID-19 outcomes in largest-yet study
Wuhan researchers found preexisting type 2 diabetes worsened prognosis of COVID-19; but those whose glucose stayed “in-range” had better outcomes...
From the Journals
Glucocorticoid use linked to mortality in RA with diabetes
Results strengthen case for treating to target, especially in more vulnerable populations.
News
In gestational diabetes, early postpartum glucose testing is a winner
GRAPEVINE, TEX. – Inpatient postpartum testing captured 99 of 100 patients without sacrificing accuracy.
